- Cisplatin resistance and opportunities for precision medicine.
Lauren Amable, 2016, Pharmacol Res CrossRef - Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy
Yue-Qin Li et al, 2018, IUBMB Life CrossRef - Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells
Tomoko Okada et al, 2013, Sci Rep CrossRef - Targeting STAT3 inhibition to reverse cisplatin resistance.
Chao-Yue Sun et al, 2019, Biomed Pharmacother CrossRef - Purinergic signalling and cancer
Geoffrey Burnstock et al, 2013, Purinergic Signalling CrossRef - Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.
Maimon C Rose et al, 2014, Genomics Proteomics Bioinformatics CrossRef - ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells
Ze Yu et al, 2020, Clin. Transl. Med. CrossRef - The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer
David Lukanović et al, 2020, Biomedicine & Pharmacotherapy CrossRef - Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Hye-Young Min et al, 2021, Arch. Pharm. Res. CrossRef - NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells.
Prerna Pandey et al, 2023, Funct Integr Genomics CrossRef - A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes
Pengchen Liang et al, 2023, Biomedicines CrossRef - ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients.
Yue-Qin Li et al, 2018, J Cancer Res Ther CrossRef - Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng et al, 2023, Advanced Materials CrossRef - Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
Jia Yee Lee et al, 2024, Biomedicine & Pharmacotherapy CrossRef